Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting

Journal of Oncology Practice

Volumn 9, Issue 6, 2013, Pages

  Somkin, Carol P ^a   Ackerson, Lynn ^a   Husson, Gail ^a   Gomez, Vicky ^a   Kolevska, Tatjana ^a   Goldstein, Desiree ^a   Fehrenbacher, Louis ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE; AWARENESS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMMUNITY TRIAL; CORRELATION ANALYSIS; CULTURAL VALUE; EXPERIENCE; FEMALE; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL ONCOLOGIST; MIDDLE AGED; NURSE; ONCOLOGIST; OPEN STUDY; PHYSICIAN ATTITUDE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84896283500     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.001120     Document Type: Article

References (36)

1. Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720-2726, 2004 (Pubitemid 38725421)
2. Brawley OW: The study of accrual to clinical trials: Can we learn from studying who enters our studies? J Clin Oncol 22:2039-2040, 2004
3. Christian MC, Trimble EL: Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiol Biomarkers Prev 12:277s-283s, 2003 (Pubitemid 36428021)
4. Sateren WB, Trimble EL, Abrams J, et al: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20:2109-2117, 2002 (Pubitemid 34408802)
5. Wagle N, Goldman DP, Kilgore M: Re: Surveys identify barriers to participation in clinical trials. J Natl Cancer Inst 93:238-239, 2001 (Pubitemid 32166497)
6. Lara PN Jr, Higdon R, Lim N, et al: Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 19:1728-1733, 2001 (Pubitemid 32230874)
7. Nass SJ, Moses HL, Mendelsohn J: A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC, National Academies Press, 2010
8. Schilsky RL: Accrual to cancer clinical trials in the era of molecular medicine. Sci Transl Med 3:75cm9, 2011
9. Young RC: Cancer clinical trials - A chronic but curable crisis. N Engl J Med 363:306-309, 2010
10. Unger JM, Hershman DL, Albain KS, et al: Patient income level and cancer clinical trial participation. J Clin Oncol 31:536-542, 2013
11. Javid SH, Unger JM, Gralow JR, et al: A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316). Oncologist 17:1180-1190, 2012
12. Klabunde CN, Keating NL, Potosky AL, et al: A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst 103:384-397, 2011
13. Schroen AT, Petroni GR, Wang H, et al: Challenges to accrual predictions to phase III cancer clinical trials: A survey of study chairs and lead statisticians of 248 NCI-sponsored trials. Clin Trials 8:591-600, 2011
14. Ford E, Jenkins V, Fallowfield L, et al: Clinicians' attitudes towards clinical trials of cancer therapy. Br J Cancer 104:1535-1543, 2011
15. Ford JG, Howerton MW, Lai GY, et al: Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer 112:228-242, 2008
16. Howerton MW, Gibbons MC, Baffi CR, et al: Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109:465-476, 2007 (Pubitemid 46190954)
17. Siminoff LA, Zhang A, Colabianchi N, et al: Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol 18:1203-1211, 2000 (Pubitemid 30159837)
18. Kemeny MM, Peterson BL, Kornblith AB, et al: Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 21:2268-2275, 2003 (Pubitemid 46621862)
19. Grand MM, O'Brien PC: Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature. J Med Imaging Radiat Oncol 56:31-39, 2012
20. Fouad MN, Lee JY, Catalano PJ, et al: Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract 9:e40-e47, 2013
21. Minasian LM, O'Mara AM: Accrual to clinical trials: Let's look at the physicians. J Natl Cancer Inst 103:357-358, 2011
22. Trimble EL, Denicoff AM, Abrams JS: Strengthening accrual to cancer clinical trials. Gynecol Oncol 116:291-292, 2010
23. Comis RL, Miller JD, Colaizzi DD, et al: Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract 5:50-56, 2009
24. Albrecht TL, Eggly SS, Gleason ME, et al: Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26:2666-2673, 2008
25. Siminoff LA, Thomas TA: Why learning to communicate with our patients is so important: Using communication to enhance accrual to cancer clinical trials. J Clin Oncol 26:2614-2615, 2008
26. Kaas R, Hart AA, Rutgers EJ: The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer. Breast 14:310-316, 2005 (Pubitemid 41110193)
27. Comis RL, Miller JD, Aldigé CR, et al: Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830-835, 2003 (Pubitemid 46606442)
28. Ulrich CM, James JL, Walker EM, et al: RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: Implications for improving patient recruitment. Contemp Clin Trials 31:221-228, 2010
29. Wright JR, Whelan TJ, Schiff S, et al: Why cancer patients enter randomized clinical trials: Exploring the factors that influence their decision. J Clin Oncol 22:4312-4318, 2004 (Pubitemid 41185152)
30. Taylor KM, Feldstein ML, Skeel RT, et al: Fundamental dilemmas of the randomized clinical trial process: Results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol 12:1796-1805, 1994 (Pubitemid 24349380)
31. Gordon NP: Similarity of the Adult Kaiser Permanente Membership in Northern California to the Insured and General Population in Northern California: Statistics from the 2009 California Health Interview Survey, Internal Division of Research Report, Kaiser Permanente Division of Research, 2012. www.dor.kaiser.org/external/chis-non-kp-2009/
32. Somkin CP, Altschuler A, Ackerson L, et al: Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care 11:413-421, 2005 (Pubitemid 41022725)
33. Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 16:37, 1951
34. Gelijns AC, Gabriel SE: Looking beyond translation-Integrating clinical research with medical practice. N Engl J Med 366:1659-1661, 2012
35. Avins AL, Goldberg H: Creating a culture of research. Contemp Clin Trials 28:557-562, 2007 (Pubitemid 46755035)
36. Zon R, Meropol NJ, Catalano RB, et al: American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites. J Clin Oncol 26:2562-2567, 2008